Department of Pharmacology, Medical School of Yangzhou University, Yangzhou, People's Republic of China.
Int J Biol Macromol. 2012 Jan 1;50(1):157-63. doi: 10.1016/j.ijbiomac.2011.10.013. Epub 2011 Oct 20.
In this paper, the method of interfacial polymerization in emulsion was employed to fabricate chondroitin sulfate-methacrylate (ChSMA) nanocapsules, in which poor water-soluble drug of indomethacin (IND) could be effectively encapsulated. The morphology and the size distribution of synthesized nanocapsules were characterized by field emission scanning electron microscopy (FESEM) and dynamic light scattering (DLS) techniques. The quantitative drug loading was investigated. The IND/ChSMA noodle-like self-assemblies were observed with the increase of IND feed concentration, and the interactions between IND and ChSMA were illuminated by FT-IR and XRD measurements. The in vitro drug release of IND-loaded nanocapsules and IND/ChSMA self-assemblies were also carried out in simulated body fluid pH 7.4 at 37°C.
本文采用乳液界面聚合法制备了硫酸软骨素-甲基丙烯酰胺(ChSMA)纳米胶囊,可有效包埋难溶于水的药物吲哚美辛(IND)。通过场发射扫描电子显微镜(FESEM)和动态光散射(DLS)技术对合成纳米胶囊的形态和粒径分布进行了表征。考察了定量载药量。随着 IND 进料浓度的增加,观察到 IND/ChSMA 面条状自组装,通过傅里叶变换红外光谱(FT-IR)和 X 射线衍射(XRD)测量揭示了 IND 和 ChSMA 之间的相互作用。还在 37°C 模拟体液 pH 7.4 下进行了载 IND 的纳米胶囊和 IND/ChSMA 自组装的体外药物释放实验。